CSIMarket Company Name, Ticker, Industry, else..
 
Qiagen N v   (NYSE: QGEN)
Other Ticker:  
 
 

QGEN's Market share relative to its competitors, as of Q4 2024

As of Q4 2024 (Revenue in Millions of $)

Date modified: 2025-05-18T08:30:00+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months
Q4 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE
A Quarter Before
Q3 2024
Qiagen N v 1,919.35 3.06% 3.06 % 0.00 %
Thermo Fisher Scientific Inc 42,898.00 68.48% 67.44% 69.45%
Agilent Technologies inc 6,519.00 10.41% 10.94% 10.28%
Illumina Inc 4,337.00 6.92% 6.77% 6.73%
Bio rad Laboratories Inc 2,565.90 4.10% 4.35% 3.95%
Bio techne Corp 1,218.24 1.94% 2.05% 1.81%
Guardant Health Inc 774.00 1.24% 1.32% 1.23%
Repligen Corp 650.43 1.04% 1.10% 1.02%
Veracyte Inc 422.81 0.67% 0.70% 0.62%
Twist Bioscience Corporation 347.68 0.55% 0.60% 0.54%
Maravai Lifesciences Holdings Inc 241.86 0.39% 0.30% 0.34%
Standard Biotools Inc 174.26 0.28% 0.31% 0.27%
Olink Holding Ab publ 169.46 0.27% 0.27% 0.00%
Nanostring Technologies Inc 162.47 0.26% 0.31% 0.27%
Pacific Biosciences Of California Inc 151.63 0.24% 0.24% 0.24%
Cue Health Inc 70.94 0.11% 0.12% 0.11%
Telesis Bio Inc 13.96 0.02% 0.01% 0.01%
Bionexus Gene Lab Corp 9.34 0.01% 0.01% 0.02%
Guided Therapeutics Inc 0.16 0.00% 0.00% 0.00%
Evaxion Biotech A 0.07 0.00% 0.00% 0.00%
SUBTOTAL 62,646.56 100% 15,367.61 100%



QGEN's Market share relative to its competitors, as of Q4 2024 within the Biotechnology & Pharmaceuticals Industry
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Qiagen N v 44.65% 45.42% 44.65 % 45.42 %
Bio techne Corp 28.34% 28.09% 28.55% 27.68%
Repligen Corp 15.13% 15.16% 15.30% 15.62%
Twist Bioscience Corporation 8.09% 7.89% 8.39% 8.27%
Nanostring Technologies Inc 3.78% 3.44% 4.35% 4.12%
Evaxion Biotech A 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



QGEN's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Qiagen N v 9.72% 9.63% 9.72 % 9.63 %
Agilent Technologies inc 33.01% 33.05% 33.60% 33.65%
Illumina Inc 21.96% 22.14% 20.80% 22.02%
Bio rad Laboratories Inc 12.99% 13.06% 13.37% 12.94%
Bio techne Corp 6.17% 5.95% 6.31% 5.92%
Guardant Health Inc 3.92% 3.74% 4.07% 4.03%
Repligen Corp 3.29% 3.21% 3.38% 3.34%
Veracyte Inc 2.14% 2.09% 2.15% 2.04%
Twist Bioscience Corporation 1.76% 1.67% 1.85% 1.77%
Maravai Lifesciences Holdings Inc 1.22% 1.31% 0.94% 1.13%
Standard Biotools Inc 0.88% 0.78% 0.96% 0.88%
Olink Holding Ab publ 0.86% 0.71% 0.86% 0.71%
Nanostring Technologies Inc 0.82% 0.73% 0.96% 0.88%
Pacific Biosciences Of California Inc 0.77% 0.78% 0.73% 0.80%
Cue Health Inc 0.36% 1.01% 0.38% 0.35%
Telesis Bio Inc 0.07% 0.09% 0.03% 0.02%
Bionexus Gene Lab Corp 0.05% 0.05% 0.04% 0.05%
Guided Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Evaxion Biotech A 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Qiagen N v's market divisions, geographic dispersion, segments, products, and services, visit Qiagen N v's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com